regdanvimab: Clinical Trials

2 trials of regdanvimab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow regdanvimab: new trials by email Literature Review of regdanvimab trials Research Report on regdanvimab

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)
CT-P59 - SARS-CoV-2 Infection
Phase 1CompletedCelltrion182020-09-042022-04-08
To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects
CT-P59, Placebo - SARS-CoV-2 Infection
Phase 1CompletedCelltrion322020-07-182021-11-16

Conditions studied

COVID-19 (2)

Sponsors

Celltrion (2)

Countries

South Korea (2)

Results publications

PMID 34473343, PMID 34551869, PMID 35713300